Kyoto, Japan

Michiaki Okuda

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michiaki Okuda: Innovator in Alzheimer's Therapeutics

Introduction

Michiaki Okuda is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic means for Alzheimer's disease. With a total of 4 patents to his name, Okuda's work is recognized for its innovative approach to addressing complex medical challenges.

Latest Patents

Among his latest patents, Okuda has developed novel pyrazole derivatives that provide therapeutic means for Alzheimer's disease. These compounds are represented by specific general formulas, showcasing their potential effectiveness in treating this debilitating condition. The detailed chemical structures highlight the innovative nature of his work, which aims to improve the quality of life for those affected by Alzheimer's.

Career Highlights

Throughout his career, Michiaki Okuda has worked with notable organizations such as Green Tech Co., Ltd. and the Tokyo Institute of Technology. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Okuda has collaborated with esteemed colleagues, including Hachiro Sugimoto and Shinichi Nakayama. These partnerships have further enhanced his research capabilities and have led to significant advancements in the pharmaceutical industry.

Conclusion

Michiaki Okuda's innovative work in developing therapeutic solutions for Alzheimer's disease underscores his importance as an inventor in the pharmaceutical field. His contributions continue to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…